期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 130, 期 48, 页码 16254-16261出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja804398y
关键词
-
资金
- NIAMS NIH HHS [T32 AR007472, K24 AR048143, T32 AR007472-19, T32AR007472] Funding Source: Medline
- NINDS NIH HHS [U54 NS048843, 08U54NS048843-05, NS58345, R21 NS058345] Funding Source: Medline
Myotonic dystrophy type 1 (DM1), the most common form of muscular dystrophy in adults, is an RNA-mediated disease. Dramatically expanded (CUG) repeats accumulate in nuclei and sequester RNA-binding proteins such as the splicing regulator MBNL1. We have employed resin-bound dynamic combinatorial chemistry (RBDCC) to identify the first examples of compounds able to inhibit MBNL1 binding to (CUG) repeat RNA, Screening an RBDCL with a theoretical diversity of 11 325 members yielded several molecules with significant selectivity for binding to (CUG) repeat RNA over other sequences. These compounds were also able to inhibit the interaction of GGG-(CLlG)(109)-GGG RNA with MBNL1 in vitro, with K-i values in the low micromolar range.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据